The U.S. equity market got off to a constructive start this morning, pulled back in the afternoon, before ending the day on a mixed note. At the close of trading, the Dow Jones Industrial Average was down about 22 points, while the broader S&P 500 Index was ahead nominally, and the NASDAQ was higher by five points. Market breadth showed a largely divided session, as advancers were just slightly ahead of decliners on the NYSE.
Finding an equity that satisfies a broad set of investment objectives is generally no easy task. Seldom do such opportunities present themselves, even within the Dow-30 crowd. But when they do, it’s important to know how to identify them. Here, we will focus on Johnson and Johnson (JNJ), a manufacturer of healthcare products, and use the latest Value Line report on this company to illustrate how effective a tool it can be when making an educated investment decision.
Shares of Bed Bath and Beyond (BBBY), the giant home furnishings outfit, have been in Wall Street’s doghouse for quite a while. Still, the core Bed Bath & Beyond brand continues to resonate with consumers. And management is taking steps to right the ship. Will these measures be enough to get the retailer back on a sustainable growth track? And does the issue, as currently valued, make an attractive 3- to 5-year turnaround play? In this brief article, we will attempt to address these questions by taking a closer look at Bed Bath & Beyond’s business and performing an easy-to-follow SWOT analysis of the company, evaluating its Strengths, Weaknesses, Opportunities, and Threats.